Bevacizumab plus irinotecan therapy in relapsed, heavily pre-treated malignant glioma: A case series

被引：0
|
作者：
Friedland, D. M. [1 ]
Ali, S. A. [1 ]
Ahmad, A. [1 ]
Rahman, M. [1 ]
Bejjani, G. [1 ]
Braffet, M. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12500
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
    Maria Antonietta De Ioris
    Francesco Fabozzi
    Francesca Del Bufalo
    Giada Del Baldo
    Maria Felicia Villani
    Maria Giuseppina Cefalo
    Maria Carmen Garganese
    Alessandra Stracuzzi
    Federica Tangari
    Arturo Maria Greco
    Isabella Giovannoni
    Roberto Carta
    Maria Luisa D’Andrea
    Angela Mastronuzzi
    Franco Locatelli
    Scientific Reports, 13
  • [2] Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
    De Ioris, Maria Antonietta
    Fabozzi, Francesco
    Del Bufalo, Francesca
    Del Baldo, Giada
    Villani, Maria Felicia
    Cefalo, Maria Giuseppina
    Garganese, Maria Carmen
    Stracuzzi, Alessandra
    Tangari, Federica
    Greco, Arturo Maria
    Giovannoni, Isabella
    Carta, Roberto
    D'Andrea, Maria Luisa
    Mastronuzzi, Angela
    Locatelli, Franco
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] Repeating radiotherapy for pre-treated malignant glioma
    Schaefer, U.
    Micke, O.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 141 - 141
  • [4] Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study
    Asmane, Irene
    Kurtz, Jean-Emmanuel
    Bajard, Agathe
    Guastalla, Jean-Paul
    Meeus, Pierre
    Tredan, Olivier
    Galy, Intidhar Labidi
    Moullet, Isabelle
    Ardisson, Philippe
    Vincent, Lionel
    Coeffic, David
    Dufresne, Armelle
    Bergerat, Jean-Pierre
    Ray-Coquard, Isabelle
    BULLETIN DU CANCER, 2011, 98 (09) : E80 - E89
  • [5] Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer
    José Miguel Jurado García
    Alfonso Sánchez
    Bella Pajares
    Elisabeth Pérez
    Lorenzo Alonso
    Emilio Alba
    Clinical and Translational Oncology, 2008, 10
  • [6] EFFICACY OF BEVACIZUMAB PLUS IRINOTECAN IN CHILDREN WITH RECURRENT OR PROGRESSIVE MALIGNANT GLIOMA
    Arakawa, Yoshiki
    Umeda, Katsutsugu
    Watanabe, Ken-ichiro
    Mizowaki, Takashi
    Hiraoka, Masahiro
    Hiramatsu, Hidefumi
    Adachi, Souichi
    Kunieda, Takeharu
    Takagi, Yasushi
    Miyamoto, Susumu
    NEURO-ONCOLOGY, 2014, 16 : 59 - 59
  • [7] Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer
    Larsen, Finn Ole
    Boisen, Mogens Karsbol
    Fromm, Annelene L.
    Jensen, Benny Vittrup
    ACTA ONCOLOGICA, 2012, 51 (02) : 231 - 233
  • [8] Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer
    Jurado Garcia, Jose Miguel
    Sanchez, Alfonso
    Pajares, Bella
    Perez, Elisabeth
    Alonso, Lorenzo
    Alba, Emilio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (09): : 583 - 586
  • [9] Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer
    José Miguel Jurado
    Alfonso Sánchez
    Bella Pajares
    Elisabeth Pérez
    Lorenzo Alonso
    Emilio Alba
    Clinical and Translational Oncology, 2008, 10 (11) : 772 - 772
  • [10] Bevacizumab toxicity in heavily pre-treated recurrent epithelial ovarian cancer
    Martin, I.
    Urban, R.
    Goff, B.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 197 - 197
12345